Reviews Influenza Virus Vaccine


No reviews yet.

Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007





Other reviews about Influenza Virus Vaccine on wordpress

FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1
  by birdflunewsflash
Well its a start! The U.S. Food and Drug Administration (FDA) today announced the first approval in the United States of a vaccine for humans against the H5N1 influenza […]


FDA Approves Influenza Vaccine for 2009-2010 Season
  by diplomatsp
The FDA has approved a seasonal influenza vaccine for the 2009-2010 season. The vaccine does not prevent infection with the H1N1 influenza virus. H1N1 influenza was declared a […]


Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
  by JOC
MMWR  Recommendations and Reports  July 31, 2009  V.58  N.RR-8  1-52 This report updates the 2008 recommendations by CDC’s Advisory Committee on Immunization Practices (ACIP) regarding the […]


allie1990 - seasonal vs H1N1 vaccine
  by mattie
October 26, 2009 Updated H1N1 posts/symptoms/vaccine Common sense re: H1N1 Hello allie1990. Normally it is a crap shoot what the seasonal flu vaccine will be comprised of. It's an educated guess as to […]


Use of Influenza A (H1N1) 2009 Monovalent Influenza Vaccine in Pregnant Women - Q & A
  by worldwebcreator
Why do the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP) recommend that pregnant women receive seasonal and influenza A (H1N1) […]


FDA approves additional vaccine for 2009 H1N1 influenza virus
  by singing2thechoir
Public Health and Healthcare Sector 23. November 16, U.S Food and Drug Administration – (National) FDA approves additional vaccine for 2009 H1N1 influenza virus. The U.S. […]


FDA Approves Additional Vaccine for 2009 H1N1 Influenza Virus
  by worldwebcreator
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID […]


Recipients of Vaccine against the 1976 “Swine Flu” Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus
  by JOC
Clinical Infectious Diseases 1 June 2010 V.50  N.11  p.1487–1492 Jonathan A. McCullers, Lee‐Ann Van De Velde, Kim J. Allison, Kristen C. Branum, Richard J. Webby, and Patricia M. Flynn Department […]


Flu Vaccines Approved For Next Winter, Will Protect Against Three Strains Of Influenza, Including H1N1
  by erickahleffert
Flu Vaccines Approved For Next Winter, Will Protect Against Three Strains Of Influenza, Including H1N1. The flu vaccines approved for the 2010-11 mature defend against three strains of […]


Vaccination Against H1N1 Flu Also Protects From The 1918 Spanish Influenza
  by erickahleffert
Vaccination Against H1N1 Flu Also Protects From The 1918 Spanish Influenza. The H1N1 influenza vaccine distributed in 2009 also appears to screen against the 1918 Spanish influenza virus […]



Other reviews about Influenza Virus Vaccine on web:

The Influenza vaccine, also known as a Flu Shot, is an annual vaccine to protect against the highly variable influenza virus. Each injected seasonal influenza vaccine contains ... Influenza vaccine - Wikipedia, the free encyclopedia


Resources for You. Consumers (Biologics) Healthcare Providers (Biologics) Industry (Biologics) About the Center for Biologics Evaluation and Research Influenza Virus Vaccine Safety & Availability


The 2010-2011 flu vaccine will protect against three different flu viruses: an H3N2 virus, an influenza B virus and the H1N1 virus that caused so much illness last season. CDC - Seasonal Influenza (Flu)


The 2010-2011 flu vaccine will protect against 2009 H1N1, and two other influenza viruses (an H3N2 virus and an influenza B virus). The viruses in the vaccine change each year based ... CDC - Seasonal Influenza (Flu) - Key Facts About Seasonal Flu Vaccine


Influenza Virus Vaccine Brand names: Fluarix™Fluarix®Flulaval™Fluogen®Flushield®Fluvirin®FluzoneFluzone® Drug influenza virus vaccine: Definition from Answers.com


influenza virus vaccine (subvirion) Intramuscular patient information. Detailed drug information for the consumer, includes dosage, influenza virus vaccine (subvirion ... influenza virus vaccine (subvirion) Intramuscular consumer ...


Afluria flu (influenza) vaccine: Manufacturer: CSL Biotherapies: Microorganism: influenza virus: Licensed: 09/28/2007: Recommendations: One intramuscular injection WAVE - Specific Vaccines Flu (influenza)


Resources for You. Consumers (Biologics) Healthcare Providers (Biologics) Industry (Biologics) About the Center for Biologics Evaluation and Research Influenza Virus Vaccine Composition and Lot Release


Influenza Virus Vaccine professional patient advice. Specific and up to date information about Influenza Virus Vaccine. Complete Influenza Virus Vaccine information from Drugs.com


The Influenza vaccine, also known as a Flu Shot, is an annual vaccine to protect against the highly variable influenza virus. Each injected seasonal influenza vaccine contains three ... Influenza vaccine - Bing Wikipedia





Featured Reviews

Reviews NegGram Caplets

NegGram Caplets Drug Description NegGram® (nalidixic acid, USP) Caplets To reduce the development of drug-resistant bacteria and maintain the effectiveness of NegGram (nalidixic acid, USP) and other antibacterial drugs, NegGram should...
Read More  |  Review This
Reviews Fosaprepitant Dimeglumine Injection

Emend Injection Drug Description EMEND (fosaprepitant dimeglumine) for Injection DRUG DESCRIPTION What are the possible side effects of fosaprepitant (Emend for Injection)? Get emergency medical help if you have any of these signs...
Read More  |  Review This
Reviews Geocillin

Geocillin Drug Description GEOCILLIN® (carbenicillin indanyl sodium) Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of Geocillin® and other antibacterial drugs, Geocillin should...
Read More  |  Review This
Reviews Oxycodone Hydrochloride

Roxicodone Drug Description ROXICODONE (oxycodone hydrochloride) Tablets USP DRUG DESCRIPTION What are the possible side effects of oxycodone? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Naprosyn, Anaprox, Anaprox DS

Naprosyn, Anaprox, Anaprox DS Drug Description EC-NAPROSYN® (naproxen) Delayed-Release Tablets NAPROSYN® (naproxen) Tablets ANAPROX®/ANAPROX® DS (naproxen sodium) Tablets NAPROSYN® (naproxen) Suspension Cardiovascular...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....